Balance Sheet Noevir Holdings Co., Ltd.

Equities

4928

JP3760450001

Personal Products

Market Closed - Japan Exchange Other stock markets 01:30:00 2026-02-06 am EST			5-day change	1st Jan Change
4,620.00 ^JPY	-2.01%		-0.96%	+0.87%

Feb. 05	Noevir Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended December 31, 2025	CI
Dec. 09	Noevir Holdings Co., Ltd. Announces Executive Changes, Effective December 9, 2025	CI

93c7bbe24465665af2b68f752d7f3ae.XjPll8K-NeAgrB30QhgJYXG-uYoAaKXiOoH11WnsPb4.GQTd06j7V7lhyXOMC25RJRna2N9VK4isbtmTvluhZMZnWKj7q9NNzWTCLQ

Published financial data: NOEVIR HOLDINGS CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024	2025
Revenues	51.27B	61.14B	62.55B	63.82B	64.72B
Total Revenues	51.27B	61.14B	62.55B	63.82B	64.72B
Cost of Goods Sold, Total	18.24B	19.05B	19.99B	20.67B	21.45B
Gross Profit	33.03B	42.09B	42.56B	43.16B	43.28B
Selling General & Admin Expenses, Total	22.44B	31.98B	31.54B	31.73B	32.2B
R&D Expenses	1.04B	-	-	-	-
Depreciation & Amortization - (IS)	989M	-	-	-	-
Other Operating Expenses, Total	24.47B	31.98B	31.54B	31.73B	32.2B
Operating Income	8.56B	10.12B	11.02B	11.42B	11.08B
Interest Expense, Total	-	-	-	-	-
Interest And Investment Income	25M	28M	54M	76M	126M
Net Interest Expenses	25M	28M	54M	76M	126M
Currency Exchange Gains (Loss)	39M	103M	1M	-24M	48M
Other Non Operating Income (Expenses)	349M	158M	215M	117M	524M
EBT, Excl. Unusual Items	8.97B	10.4B	11.29B	11.59B	11.77B
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-6M	103M	3M	25M	19M
Asset Writedown	-	-310M	-	-	-
Other Unusual Items	-	961M	-	-	86M
EBT, Incl. Unusual Items	8.96B	11.16B	11.3B	11.62B	11.88B
Income Tax Expense	2.51B	3.51B	3.48B	3.53B	3.69B
Earnings From Continuing Operations	6.46B	7.65B	7.81B	8.09B	8.19B
Net Income to Company	6.46B	7.65B	7.81B	8.09B	8.19B
Minority Interest	-76M	-64M	-140M	-118M	-159M
Net Income - (IS)	6.38B	7.59B	7.67B	7.97B	8.03B
Net Income to Common Incl Extra Items	6.38B	7.59B	7.67B	7.97B	8.03B
Net Income to Common Excl. Extra Items	6.38B	7.59B	7.67B	7.97B	8.03B
Per Share Items
Net EPS - Basic	186.88	222.18	224.64	233.34	235.1
Basic EPS - Continuing Operations	186.88	222.18	224.64	233.34	235.1
Basic Weighted Average Shares Outstanding	34.16M	34.16M	34.16M	34.16M	34.16M
Net EPS - Diluted	186.88	222.18	224.64	233.34	235.1
Diluted EPS - Continuing Operations	186.88	222.18	224.64	233.34	235.1
Diluted Weighted Average Shares Outstanding	34.16M	34.16M	34.16M	34.16M	34.16M
Normalized Basic EPS	161.93	188.52	202.56	208.68	210.79
Normalized Diluted EPS	161.93	188.52	202.56	208.68	210.79
Dividend Per Share	210	215	220	225	230
Payout Ratio	109.7	94.43	95.67	94.38	95.68
Supplemental Items
EBITDA	10.05B	11.57B	12.24B	12.43B	11.94B
EBITA	8.59B	10.15B	11.06B	11.46B	11.11B
EBIT	8.56B	10.12B	11.02B	11.42B	11.08B
Effective Tax Rate - (Ratio)	27.95	31.42	30.84	30.38	31.06
Normalized Net Income	5.53B	6.44B	6.92B	7.13B	7.2B
Non-Cash Pension Expense	12M	25M	9M	10M	0
Supplemental Operating Expense Items
Advertising Expense	4.88B	2.88B	2.72B	2.82B	2.77B
Selling and Marketing Expenses	4.88B	11.06B	10.69B	10.92B	10.91B
Research And Development Expense From Footnotes	1.04B	1.06B	1.03B	1.07B	1.13B

Fiscal Period: September	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	31.1B	29.75B	28.88B	29.22B	26.93B
Total Cash And Short Term Investments	31.1B	29.75B	28.88B	29.22B	26.93B
Accounts Receivable, Total	9.29B	8.96B	10.49B	10.78B	12.1B
Other Receivables	2.84B	3.39B	3.06B	-	-
Total Receivables	12.12B	12.35B	13.55B	10.78B	12.1B
Inventory	7.33B	7.85B	8.15B	8.09B	7.68B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	574M	619M	600M	2.05B	2.17B
Total Current Assets	51.13B	50.57B	51.18B	50.15B	48.88B
Net Property Plant And Equipment	22.04B	20.69B	20.19B	19.91B	21.4B
Long-term Investments	4.14B	3.37B	3.72B	4.24B	3.96B
Goodwill	240M	209M	178M	158M	125M
Other Intangibles, Total	191M	209M	521M	836M	1.06B
Deferred Tax Assets Long-Term	2.7B	1.73B	1.46B	1.19B	1.07B
Other Long-Term Assets, Total	1M	2M	1M	1M	1M
Total Assets	80.45B	76.78B	77.25B	76.47B	76.49B
Liabilities
Accounts Payable, Total	2.59B	2.94B	2.9B	2.95B	3.24B
Accrued Expenses, Total	102M	101M	97M	97M	25M
Current Portion of Leases	112M	93M	87M	86M	85M
Current Income Taxes Payable	4.05B	4.28B	5.16B	3.66B	4.2B
Other Current Liabilities	1.78B	2.24B	2.26B	2.53B	2.29B
Total Current Liabilities	8.64B	9.65B	10.51B	9.32B	9.85B
Long-Term Leases	1B	912M	827M	742M	657M
Pension & Other Post Retirement Benefits	5.53B	514M	534M	557M	9M
Deferred Tax Liability Non Current	492M	311M	461M	658M	690M
Other Non Current Liabilities	12.56B	13.01B	11.71B	11.29B	11.08B
Total Liabilities	28.22B	24.4B	24.04B	22.57B	22.28B
Common Stock, Total	7.32B	7.32B	7.32B	7.32B	7.32B
Retained Earnings	43.04B	42.98B	43.31B	43.77B	44.11B
Treasury Stock	-1M	-1M	-1M	-2M	-2M
Comprehensive Income and Other	1.57B	1.76B	2.16B	2.39B	2.34B
Total Common Equity	51.92B	52.06B	52.79B	53.48B	53.77B
Minority Interest	306M	328M	415M	428M	441M
Total Equity	52.23B	52.38B	53.2B	53.9B	54.21B
Total Liabilities And Equity	80.45B	76.78B	77.25B	76.47B	76.49B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	34.16M	34.16M	34.16M	34.16M	34.16M
ECS Total Common Shares Outstanding	34.16M	34.16M	34.16M	34.16M	34.16M
Book Value / Share	1.52K	1.52K	1.55K	1.57K	1.57K
Tangible Book Value	51.49B	51.64B	52.09B	52.48B	52.58B
Tangible Book Value Per Share	1.51K	1.51K	1.53K	1.54K	1.54K
Total Debt	1.11B	1B	914M	828M	742M
Net Debt	-29.99B	-28.74B	-27.97B	-28.4B	-26.19B
Debt Equivalent of Unfunded Proj. Benefit Obligation	5.53B	514M	534M	557M	9M
Minority Interest, Total (Incl. Fin. Div)	306M	328M	415M	428M	441M
Inventories - Raw Materials, Total	1.26B	1.47B	1.65B	1.67B	1.52B
Inventories - Work In Process, Total	116M	140M	141M	112M	183M
Inventories - Finished Goods, Total	5.95B	6.24B	6.35B	6.31B	5.97B
Full Time Employees	1.45K	1.4K	1.37K	1.37K	1.35K
Accumulated Allowance for Doubtful Accounts (Supple)	20M	7M	6M	5M	7M

Fiscal Period: September	2021	2022	2023	2024	2025
Net Income	8.97B	11.16B	11.3B	11.62B	11.88B
Depreciation & Amortization - CF	1.46B	1.42B	1.19B	977M	832M
Amortization of Goodwill and Intangible Assets - (CF)	31M	31M	31M	32M	33M
Depreciation & Amortization, Total	1.49B	1.45B	1.22B	1.01B	865M
(Gain) Loss From Sale Of Asset	6M	207M	-2M	-24M	-19M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Other Operating Activities, Total	-1.91B	-3.38B	-1.92B	-2.16B	-3.29B
Change In Accounts Receivable	-47M	-343M	-1.52B	-298M	-1.3B
Change In Inventories	801M	-284M	-261M	46M	439M
Change In Accounts Payable	413M	282M	-39M	50M	276M
Change in Other Net Operating Assets	-656M	-3.25B	-1.15B	-1.11B	-927M
Cash from Operations	9.06B	5.84B	7.62B	9.12B	7.93B
Capital Expenditure	-376M	-546M	-736M	-626M	-2.27B
Sale of Property, Plant, and Equipment	20M	312M	10M	37M	40M
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-57M	-67M	-316M	-384M	-252M
Investment in Marketable and Equity Securities, Total	-1M	46M	-2.5B	2.5B	62M
Other Investing Activities, Total	-2M	-	-1M	-1M	-1M
Cash from Investing	-416M	-255M	-3.54B	1.52B	-2.42B
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-7B	-7.17B	-7.34B	-7.52B	-7.68B
Common & Preferred Stock Dividends Paid	-7B	-7.17B	-7.34B	-7.52B	-7.68B
Other Financing Activities, Total	-179M	-214M	-152M	-190M	-241M
Cash from Financing	-7.18B	-7.38B	-7.49B	-7.71B	-7.92B
Foreign Exchange Rate Adjustments	159M	479M	49M	-96M	130M
Miscellaneous Cash Flow Adjustments	16M	1M	-	-	-
Net Change in Cash	1.64B	-1.31B	-3.36B	2.84B	-2.28B
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	2.3B	3.37B	1.98B	2.16B	3.23B
Levered Free Cash Flow	8.4B	7.4B	6.45B	7.32B	4.77B
Unlevered Free Cash Flow	8.4B	7.4B	6.45B	7.32B	4.77B
Change In Net Working Capital	-1.99B	-238M	611M	-185M	504M

Fiscal Period: September	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.67	8.04	8.95	9.29	9.05
Return on Total Capital	10.02	11.85	12.82	13.12	12.62
Return On Equity %	12.36	14.63	14.8	15.1	15.15
Return on Common Equity	12.29	14.6	14.64	15	14.98
Margin Analysis
Gross Profit Margin %	64.42	68.84	68.05	67.62	66.87
SG&A Margin	43.77	52.3	50.42	49.72	49.75
EBITDA Margin %	19.61	18.92	19.57	19.48	18.45
EBITA Margin %	16.75	16.6	17.67	17.95	17.16
EBIT Margin %	16.69	16.54	17.62	17.9	17.11
Income From Continuing Operations Margin %	12.6	12.52	12.49	12.67	12.65
Net Income Margin %	12.45	12.41	12.27	12.49	12.41
Net Avail. For Common Margin %	12.45	12.41	12.27	12.49	12.41
Normalized Net Income Margin	10.79	10.53	11.06	11.17	11.12
Levered Free Cash Flow Margin	16.39	12.1	10.31	11.48	7.36
Unlevered Free Cash Flow Margin	16.39	12.1	10.31	11.48	7.36
Asset Turnover
Asset Turnover	0.64	0.78	0.81	0.83	0.85
Fixed Assets Turnover	2.28	2.86	3.06	3.18	3.13
Receivables Turnover (Average Receivables)	5.54	6.7	6.43	6	5.66
Inventory Turnover (Average Inventory)	2.37	2.51	2.5	2.55	2.72
Short Term Liquidity
Current Ratio	5.92	5.24	4.87	5.38	4.96
Quick Ratio	5	4.36	4.04	4.29	3.96
Operating Cash Flow to Current Liabilities	1.05	0.61	0.73	0.98	0.81
Days Sales Outstanding (Average Receivables)	65.84	54.47	56.75	60.99	64.53
Days Outstanding Inventory (Average Inventory)	154.15	145.42	146.04	143.78	134.22
Average Days Payable Outstanding	49.45	51.54	52.52	51.98	53.71
Cash Conversion Cycle (Average Days)	170.54	148.34	150.27	152.8	145.05
Long Term Solvency
Total Debt/Equity	2.13	1.92	1.72	1.54	1.37
Total Debt / Total Capital	2.08	1.88	1.69	1.51	1.35
LT Debt/Equity	1.91	1.74	1.55	1.38	1.21
Long-Term Debt / Total Capital	1.87	1.71	1.53	1.36	1.2
Total Liabilities / Total Assets	35.07	31.78	31.12	29.51	29.13
EBIT / Interest Expense	-	-	-	-	-
EBITDA / Interest Expense	-	-	-	-	-
(EBITDA - Capex) / Interest Expense	-	-	-	-	-
Total Debt / EBITDA	0.11	0.09	0.07	0.07	0.06
Net Debt / EBITDA	-2.98	-2.48	-2.28	-2.28	-2.19
Total Debt / (EBITDA - Capex)	0.11	0.09	0.08	0.07	0.08
Net Debt / (EBITDA - Capex)	-3.1	-2.61	-2.43	-2.4	-2.71
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-1.1	19.25	2.3	2.03	1.41
Gross Profit, 1 Yr. Growth %	-0.15	27.43	1.12	1.39	0.28
EBITDA, 1 Yr. Growth %	2.99	15.07	5.85	1.54	-3.96
EBITA, 1 Yr. Growth %	6.14	18.14	8.95	3.63	-3.03
EBIT, 1 Yr. Growth %	6.17	18.21	8.98	3.63	-3.05
Earnings From Cont. Operations, 1 Yr. Growth %	13.69	18.49	2.09	3.52	1.25
Net Income, 1 Yr. Growth %	13.62	18.89	1.11	3.87	0.75
Normalized Net Income, 1 Yr. Growth %	8.71	16.42	7.45	3.02	1.01
Diluted EPS Before Extra, 1 Yr. Growth %	13.62	18.89	1.11	3.87	0.75
Accounts Receivable, 1 Yr. Growth %	0.84	-3.49	17.03	2.8	12.24
Inventory, 1 Yr. Growth %	-9.25	7.08	3.78	-0.68	-5.06
Net Property, Plant and Equip., 1 Yr. Growth %	-4.27	-6.12	-2.41	-1.42	7.48
Total Assets, 1 Yr. Growth %	0.49	-4.56	0.61	-1	0.03
Tangible Book Value, 1 Yr. Growth %	-0.1	0.28	0.88	0.75	0.19
Common Equity, 1 Yr. Growth %	-0.1	0.25	1.41	1.3	0.54
Cash From Operations, 1 Yr. Growth %	23.95	-35.51	30.44	19.66	-13.1
Capital Expenditures, 1 Yr. Growth %	-77	45.21	34.8	-14.95	261.98
Levered Free Cash Flow, 1 Yr. Growth %	56.8	-11.94	-12.86	13.6	-34.93
Unlevered Free Cash Flow, 1 Yr. Growth %	56.8	-11.94	-12.86	13.6	-34.93
Dividend Per Share, 1 Yr. Growth %	2.44	2.38	2.33	2.27	2.22
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-6.98	8.6	10.45	2.17	1.72
Gross Profit, 2 Yr. CAGR %	-7.03	12.8	13.52	1.26	0.84
EBITDA, 2 Yr. CAGR %	-14.69	8.86	10.37	3.68	-1.25
EBITA, 2 Yr. CAGR %	-15.41	11.98	13.45	6.25	0.24
EBIT, 2 Yr. CAGR %	-15.53	12.02	13.5	6.27	0.24
Earnings From Cont. Operations, 2 Yr. CAGR %	-6.08	16.07	9.98	2.8	2.38
Net Income, 2 Yr. CAGR %	-6.01	16.23	9.64	2.48	2.3
Normalized Net Income, 2 Yr. CAGR %	-14.45	12.5	11.85	5.21	2.01
Diluted EPS Before Extra, 2 Yr. CAGR %	-6.01	16.23	9.64	2.48	2.3
Accounts Receivable, 2 Yr. CAGR %	-7.23	-1.35	6.27	9.68	7.42
Inventory, 2 Yr. CAGR %	-7.9	-1.42	5.42	1.53	-2.89
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.56	-5.2	-4.28	-1.92	2.94
Total Assets, 2 Yr. CAGR %	-1.74	-2.06	-2.01	-0.2	-0.49
Tangible Book Value, 2 Yr. CAGR %	-0.71	0.09	0.58	0.81	0.47
Common Equity, 2 Yr. CAGR %	-0.76	0.08	0.83	1.36	0.92
Cash From Operations, 2 Yr. CAGR %	-5.7	-10.59	-8.28	24.93	1.97
Capital Expenditures, 2 Yr. CAGR %	-54.7	-42.21	39.91	7.08	75.47
Levered Free Cash Flow, 2 Yr. CAGR %	-4.97	17.51	-12.4	-0.5	-14.02
Unlevered Free Cash Flow, 2 Yr. CAGR %	-4.97	17.51	-12.4	-0.5	-14.02
Dividend Per Share, 2 Yr. CAGR %	2.47	2.41	2.35	2.3	2.25
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-3.93	1.05	6.46	7.57	1.92
Gross Profit, 3 Yr. CAGR %	-3.92	3.28	8.76	9.32	0.93
EBITDA, 3 Yr. CAGR %	-8.77	-5.74	7.85	7.34	1.07
EBITA, 3 Yr. CAGR %	-8.98	-5.45	10.96	10.08	3.07
EBIT, 3 Yr. CAGR %	-8.97	-5.52	11	10.11	3.07
Earnings From Cont. Operations, 3 Yr. CAGR %	-6.56	1.48	11.21	7.79	2.28
Net Income, 3 Yr. CAGR %	-6.63	1.65	10.95	7.68	1.9
Normalized Net Income, 3 Yr. CAGR %	-8.24	-5.2	10.79	8.82	3.79
Diluted EPS Before Extra, 3 Yr. CAGR %	-6.49	1.65	10.95	7.68	1.9
Accounts Receivable, 3 Yr. CAGR %	-7.52	-6	4.43	5.1	10.53
Inventory, 3 Yr. CAGR %	-3.55	-3.16	0.28	3.35	-0.71
Net Property, Plant and Equip., 3 Yr. CAGR %	-1.19	-3.76	-4.28	-3.34	1.12
Total Assets, 3 Yr. CAGR %	-0.96	-2.69	-1.18	-1.68	-0.13
Tangible Book Value, 3 Yr. CAGR %	-0.08	-0.38	0.35	0.64	0.61
Common Equity, 3 Yr. CAGR %	0.06	-0.43	0.52	0.99	1.08
Cash From Operations, 3 Yr. CAGR %	22.21	-16.92	1.4	0.22	10.69
Capital Expenditures, 3 Yr. CAGR %	-33.19	-33.2	-23.36	18.52	60.7
Levered Free Cash Flow, 3 Yr. CAGR %	36.82	-7.35	6.36	-4.47	-13.64
Unlevered Free Cash Flow, 3 Yr. CAGR %	36.82	-7.35	6.36	-4.47	-13.64
Dividend Per Share, 3 Yr. CAGR %	5.27	2.44	2.38	2.33	2.27
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	0.04	2.34	1.58	1.5	4.54
Gross Profit, 5 Yr. CAGR %	-0.09	3.31	2.71	2.46	5.52
EBITDA, 5 Yr. CAGR %	1.34	-0.53	-1.55	-2.08	4.12
EBITA, 5 Yr. CAGR %	2.07	0.23	-0.59	-0.93	6.54
EBIT, 5 Yr. CAGR %	2.12	0.26	-0.57	-0.97	6.56
Earnings From Cont. Operations, 5 Yr. CAGR %	4.89	1.39	-0.27	2.01	7.59
Net Income, 5 Yr. CAGR %	4.8	1.41	-0.43	1.98	7.41
Normalized Net Income, 5 Yr. CAGR %	2.64	0.23	-0.68	-1.16	7.19
Diluted EPS Before Extra, 5 Yr. CAGR %	5.58	2.16	-0.34	1.98	7.41
Accounts Receivable, 5 Yr. CAGR %	-3.07	-5.51	-2.23	-0.01	5.62
Inventory, 5 Yr. CAGR %	0.31	1.72	-0.06	-1.31	-1
Net Property, Plant and Equip., 5 Yr. CAGR %	-1.85	-2.42	-2.44	-3.03	-1.45
Total Assets, 5 Yr. CAGR %	-2.16	-3.88	-1.38	-1.7	-0.91
Tangible Book Value, 5 Yr. CAGR %	-1.47	-2.59	0.19	0.1	0.4
Common Equity, 5 Yr. CAGR %	-1.42	-2.53	0.37	0.28	0.68
Cash From Operations, 5 Yr. CAGR %	8.74	-6.4	8.96	-2.19	1.63
Capital Expenditures, 5 Yr. CAGR %	-25.96	-18.48	-10.21	-19.33	6.75
Levered Free Cash Flow, 5 Yr. CAGR %	19.94	3.81	14.47	-4.67	-2.32
Unlevered Free Cash Flow, 5 Yr. CAGR %	19.94	3.81	14.47	-4.67	-2.32
Dividend Per Share, 5 Yr. CAGR %	11.84	7.47	4.1	2.38	2.33